首页> 美国卫生研究院文献>Frontiers in Cellular and Infection Microbiology >Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment
【2h】

Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment

机译:肽基精氨酸脱亚氨酶抑制剂可降低细菌膜囊泡的释放并使细菌对抗生素治疗敏感。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Outer membrane and membrane vesicles (OMV/MV) are released from bacteria and participate in cell communication, biofilm formation and host-pathogen interactions. Peptidylarginine deiminases (PADs) are phylogenetically conserved enzymes that catalyze post-translational deimination/citrullination of proteins, causing structural and functional changes in target proteins. PADs also play major roles in the regulation of eukaryotic extracellular vesicle release. Here we show phylogenetically conserved pathways of PAD-mediated OMV/MV release in bacteria and describe deiminated/citrullinated proteins in E. coli and their derived OMV/MVs. Furthermore, we show that PAD inhibitors can be used to effectively reduce OMV/MV release, both in Gram-negative and Gram-positive bacteria. Importantly, this resulted in enhanced antibiotic sensitivity of both E. coli and S. aureus to a range of antibiotics tested. Our findings reveal novel strategies for applying pharmacological OMV/MV-inhibition to reduce antibiotic resistance.
机译:外膜和膜囊泡(OMV / MV)从细菌中释放出来,并参与细胞通讯,生物膜形成和宿主-病原体相互作用。肽基精氨酸脱亚氨酶(PAD)是系统进化上保守的酶,可催化蛋白质的翻译后去氨化/瓜氨酸化,从而导致靶标蛋白质的结构和功能发生变化。 PADs在真核细胞外小泡释放的调节中也起着重要作用。在这里,我们显示了细菌中PAD介导的OMV / MV释放的系统发育保守途径,并描述了大肠杆菌中的端基化/瓜氨酸化蛋白及其衍生的OMV / MV。此外,我们表明,PAD抑制剂可用于有效减少革兰氏阴性菌和革兰氏阳性菌中的OMV / MV释放。重要的是,这导致大肠杆菌和金黄色葡萄球菌对一系列测试抗生素的敏感性增强。我们的发现揭示了应用药理性OMV / MV抑制作用来降低抗生素耐药性的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号